Learning Objective
- Illustrate the Indian pharmaceutical and intellectual property environment; and highlight the tradeoffs faced by startups expanding into new sectors.
Abstract
Biocon India Group has just formed a new subsidiary, Clinigene, to provide services in clinical trials. Concerns abound, however, as to whether this new subsidiary could prove to be a distraction or worse to this enzyme and pharmaceutical manufacturer.
We want people with scientific backgrounds because it makes it much easier for people to talk to one another. They are familiar with the jargon and accustomed to scientific concepts, and this facilitates dialogue and fitting in.
Appropriate for the Following Course(s)
Global entrepreneurship, Strategy
THERE IS NO TEACHING NOTE FOR THIS CASE STUDY.